Development of a novel, cost-effective, platform-based cell-sorting solution superior to current best-in-class

Cell Lane （CL）由Chris Wood博士（高频和介孔电子学副教授），Christoph Wälti（生物纳米技术教授）和Jennifer Kirkham（口腔生物学教授）创立，是一家不断发展的英国中小企业，专门从事细胞分离技术，以支持下一代再生细胞疗法。目前的细胞分离技术要么效率低下，要么成本高昂，要么会引入杂质，从而减缓了细胞疗法的进展，以治疗一系列损伤和疾病，包括癌症、帕金森氏病、糖尿病和中风。CL旨在提供一种新颖、经济、基于平台的细胞分选解决方案，优于当前同类最佳技术。CL计划项目后第5年的收入为460万至620万英镑。

Founded by Dr Chris Wood (Associate Professor of High-Frequency and Mesoscopic Electronics), Christoph Wälti (Professor of Bionanotechnology) and Jennifer Kirkham (Professor of Oral Biology), Cell Lane (CL) is a growing UK-based SME specialising in cell-separation technologies to support next generation, regenerative cell therapies. Current cell-separation technologies are either inefficient, costly or introduce impurities, thereby slowing the advancement of cell therapies to treat a range of injuries and disease including cancer, Parkinson's disease, diabetes and stroke. CL aims to provide a novel, cost-effective, platform-based, cell-sorting solution superior to current best-in-class technologies. CL proposes a year-5 post-project revenue of £4.6M--6.2M.